Orsythia
Product Images NDC 53002-3647

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Orsythia (NDC 53002-3647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530023647)

Orsythia 0.01/0.02mg Tablets 28-Day, oral contraceptive tablets by RPK Pharmaceuticals, Inc. The 1-month pack label includes directions to take one tablet daily, prescription use only, and placeholders for patient and prescriber information. The carton and label display NDC 53002-3647 with details such as lot number and expiration date.*

FDA Label Image

Chemical Structure (Orsythia 0254 1)

Chemical structures of Levonorgestrel and Ethinyl Estradiol are shown. The top structure represents Levonorgestrel with molecular formula C21H28O2 and molecular weight 312.4. The bottom structure represents Ethinyl Estradiol with molecular formula C20H24O2 and molecular weight 296.4.*

FDA Label Image

Figure 1 (Orsythia 0254 2)

Two line graphs depicting the concentration of Levonorgestrel and Ethinyl Estradiol in the bloodstream over time. Each graph shows concentration in ng/mL or pg/mL on the vertical axis and time in hours on the horizontal axis, with data points for Day 1, Day 6, and Day 21. Error bars indicate variability in measurements.*

FDA Label Image

Figure 2.jpg (Orsythia 0254 3)

A bar graph comparing data among four groups: ever-users (nonsmokers), controls (nonsmokers), ever-users (smokers), and controls (smokers), across age groups 15-24, 25-34, 35-44, and 45 and older. The vertical axis likely represents a count or measure, with the highest bar observed in the 45 and older group for ever-users (smokers).*

FDA Label Image

Blister Image (Orsythia 0254 4)

Orsythia medication blister card with a 28-day calendar pill layout. It shows four rows labeled Week 1 through Week 4, each containing seven circular pill compartments aligned to days of the week from Sunday to Saturday. Pills for Week 4 are shaded, indicating inactive or placebo tablets. Orsythia contains ethinyl estradiol and drospirenone, as indicated on the packaging.*

FDA Label Image

Blister Image (Orsythia 0254 5)

Packaging label for Orsythia tablets showing a multi-week pill calendar. The label includes four rows indicating weeks 1 to 4 with circular markers for each day from Sunday to Saturday. Week 4's markers are shaded. The label includes the dosage information: levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg tablets USP, and the product name Orsythia is prominently displayed along the right side. The labeler is RPK Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.